BioNTech SE
98.13USD
-0.5300 (-0.54%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|
| Revenue | 106 | 118 | 907 | 1,519 | 261 |
| Cost of Revenue | 97 | 71 | 333 | 148 | 76 |
| Gross Profit | 9 | 47 | 574 | 1,371 | 184 |
| Operating Income | -939 | -671 | -281 | 654 | -472 |
| Net Income | -821 | -532 | -305 | -29 | -387 |
| EPS (Diluted) | $-3.24 | $-2.10 | $-1.25 | $-0.12 | $-1.60 |
Source: Yahoo Finance (limited history)